REMICADE® can help change the face of Crohn’s disease symptoms, with rapid relief in as little as 2 weeks and lasting symptom control (based on a 1-year study)
If you're one of the half-million people with Crohn’s, you know all too well how this condition can affect your life. Crohn’s is an ongoing and serious condition that causes inflammation of the digestive (or gastrointestinal [GI]) tract. Although it may involve any area of the GI tract, it usually affects the small intestine or colon.
People with Crohn’s usually experience periods when symptoms worsen, called a "flare," which alternate with periods when the disease is inactive (few or no symptoms), called "remission." However, even when the disease is inactive, Crohn’s does not really go away. Sooner or later another flare will occur. This cycle of flares is common for people with Crohn’s. The main goals of treatment are to reach and then maintain remission.
For adult patients with moderately to severely active Crohn’s who haven't responded well to other therapies, REMICADE® may help. REMICADE® is a biologic, which is part of a class of treatments.
REMICADE® can help you gain long-lasting control over symptoms and flares, as shown in a 1-year clinical study.
REMICADE® can reduce signs and symptoms and induce and maintain remission in adult patients with moderately to severely active Crohn’s who haven't responded well to other therapies.
REMICADE® can lower your ability to fight infections. Serious and sometimes fatal events can occur. There have been reports of serious infections including tuberculosis (TB) and infections caused by bacteria, fungi, or viruses that have spread throughout the body. Lymphoma, including a fatal kind called hepatosplenic T-cell lymphoma, and other cancers have been reported in children and adults taking REMICADE®. Some people with heart failure should not take REMICADE®. Other serious side effects reported include skin cancer, hepatitis B, liver injury, blood problems, allergic reactions, nervous system problems, or lupus-like syndrome. To learn more about these and other risks, please read the Important Safety Information and the Medication Guide , and talk with your doctor.